AstraZeneca looking outside for drugs

AstraZeneca has trailed rivals such as Novartis and Pfizer in its willingness to purchase promising drugs that were discovered outside their own laboratories, and the drugmaker now is playing catch-up. Over the past few months AstraZeneca has signed several deals totaling up to $1.6 billion to license drug candidates and may be considering additional alliances.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC